Impact of Novel Approaches to Systemic Lupus Erythematosus: Evolution of Treatment and Management Strategies to Optimize Patients Care - Physician

Jointly provided by Med Learning Group and Amedco.

Supported by an Educational Grant from Lilly USA, LLC.

Scroll to the Bottom of this Information to Begin This Course

Release date: October 17, 2014

Valid through: October 17, 2015

Specialty: Rheumatology

Topic: Systemic Lupus Erythematosus

Estimated Time to Complete Activity:  60 minutes

Target Audience

This CME initiative is designed to meet the educational needs of pharmacists, specialty pharmacy professionals and other healthcare providers involved in the treatment of patients with systemic lupus.

Program Overview

This case-based enduring activity will discuss the treatment and management strategies to optimize care of patients with systemic lupus erythematosus.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Employ the new SLICC criteria to more accurately classify patients with mild, moderate, and severe disease, while reviewing potential limitation of disease activity indices and visual analog scales
  • Discuss the benefits and limitations of current agents for SLE and differentiate biologic therapies from conventional therapies
  • Evaluate clinical trial evidence for the potential safety, tolerability, and efficacy of agents in development for SLE
  • Discuss risk factors for comorbidities associated with SLE and their impact on treatment considerations
  • Outline the considerations for individualized treatment, strategies for setting treatment goals, and, predictive factors for nonadherence

Credit Available

  • Physicians — maximum of 1.5 AMA PRA Category 1 Credits

Pharmacists should take Impact of Novel Approaches to Systemic Lupus Erythematosus: Evolution of Treatment and Management Strategies to Optimize Patients Care - Pharmacist for 1.5 Credit Hours

All other healthcare professionals completing this course will be issued a statement of participation.

Faculty

Daniel J. Wallace, MD, Chair
Clinical Professor of Medicine
David Geffen School of Medicine
University of California Los Angeles
Attending Physician
Cedars Sinai Medical Center
Los Angeles, California

MLG Course Reviewer
M. Susan Burke, MD, FACP
Clinical Assistant Professor, Internal Medicine
Thomas Jefferson University Medical School
Philadelphia, Pennsylvania
Senior Advisor, Internal Medicine Clinical Care Center
Lankenau Medical Center
Wynnewood, Pennsylvania

Pharmacy Reviewer
Kristine Poloyac, RPh
Critical Care Trauma Unit Based Clinical Pharmacist
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania 15213

Physician Continuing Medical Education

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

Credit Designation

Med Learning Group designates this enduring activity for a maximum of 1.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Dr. Daniel Wallace serves as a consultant and is on the speakers' bureaus for Abbvie, GSK, Lilly, Merck Sereno, Pfizer, and UCB. For ACPE purposes, the ACPE provider, Amedco, has determined that Dr. Daniel Wallace has no relevant financial relationship to disclose.

Dr. Susan Burke (MLG Course Reviewer) has no relevant financial relationships to disclose.

Kristine Poloyac (Pharmacy Reviewer) has no relevant financial relationships to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, General Manager of Med Learning Group has nothing to disclose.

Christina Gallo, CCMEP, SVP, Educational Development for Med Learning Group has nothing to disclose.

Lauren Welch, VP of Accreditation and Outcomes for Med Learning Group has nothing to disclose.

Flavia Piazza, VP, Medical and Scientific Services for Med Learning Group has nothing to disclose.

Disclosure of Unlabeled Use

Med Learning Group requires that faculty participating in any CME/CNE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, Dr. Wallace may mention the use of medications for both FDA-approved and non-approved indications.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CE credit participants must:

  • Read the learning objectives and faculty disclosures.
  • Complete the pre-test.
  • Participate in the activity.
  • Complete the post-test and activity evaluation
  • Physicians who successfully complete the post-test and evaluation will receive CME credit.
  • All non-physician participants who successfully complete the post-test and evaluation will receive a certificate of participation.
  • You will receive your certificate for download immediately, you will also get an email reminder.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

Media

Internet

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.

Disclaimer

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Participation Statement

This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

Content - Copyright © 2014 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.